Kuros Biosciences AG
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technol… Read more
Market Cap & Net Worth: Kuros Biosciences AG (CSBTF)
Kuros Biosciences AG (PINK:CSBTF) has a market capitalization of $783.90 Million ($783.90 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #9447 globally and #4543 in its home market, demonstrating a -9.25% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Kuros Biosciences AG's stock price $20.01 by its total outstanding shares 39175300 (39.18 Million).
Kuros Biosciences AG Market Cap History: 2015 to 2025
Kuros Biosciences AG's market capitalization history from 2015 to 2025. Data shows growth from $1.13 Billion to $783.90 Million (0.00% CAGR).
Kuros Biosciences AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Kuros Biosciences AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
14.36x
Kuros Biosciences AG's market cap is 14.36 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.13 Billion | $6.36 Million | $6.23 Million | 177.09x | 180.73x |
| 2016 | $812.39 Million | $1.06 Million | -$19.74 Million | 765.69x | N/A |
| 2018 | $91.13 Million | $715.00K | -$11.69 Million | 127.45x | N/A |
| 2019 | $12.70 Million | $2.56 Million | -$11.25 Million | 4.96x | N/A |
| 2020 | $94.02 Million | $4.04 Million | -$11.52 Million | 23.28x | N/A |
| 2021 | $99.90 Million | $13.81 Million | -$7.54 Million | 7.23x | N/A |
| 2022 | $75.22 Million | $17.99 Million | -$14.60 Million | 4.18x | N/A |
| 2023 | $150.84 Million | $33.56 Million | -$13.73 Million | 4.49x | N/A |
| 2024 | $1.09 Billion | $75.56 Million | -$3.72 Million | 14.36x | N/A |
Competitor Companies of CSBTF by Market Capitalization
Companies near Kuros Biosciences AG in the global market cap rankings as of March 18, 2026.
Key companies related to Kuros Biosciences AG by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
Kuros Biosciences AG Historical Marketcap From 2015 to 2025
Between 2015 and today, Kuros Biosciences AG's market cap moved from $1.13 Billion to $ 783.90 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $783.90 Million | -27.76% |
| 2024 | $1.09 Billion | +619.39% |
| 2023 | $150.84 Million | +100.55% |
| 2022 | $75.22 Million | -24.71% |
| 2021 | $99.90 Million | +6.25% |
| 2020 | $94.02 Million | +640.51% |
| 2019 | $12.70 Million | -86.07% |
| 2018 | $91.13 Million | -88.78% |
| 2016 | $812.39 Million | -27.81% |
| 2015 | $1.13 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Kuros Biosciences AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $783.90 Million USD |
| MoneyControl | $783.90 Million USD |
| MarketWatch | $783.90 Million USD |
| marketcap.company | $783.90 Million USD |
| Reuters | $783.90 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.